How much funding has Embleema raised?

Embleema has raised $4.1M in total funding, most recently a series a round.

Who are Embleema's investors?

Embleema's investors include Pharmagest, MassChallenge, Techstars.

Where is Embleema headquartered?

Embleema is headquartered in New York, New York, United States.

What industry is Embleema in?

Embleema operates in Crypto & Web3, Healthcare.

Embleema

New York, United States · Founded 2019 · $4.1M raised

Crypto & Web3

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: embleema.com
Total Funding: $4.1M
Last Round: $3.7M Series AFeb 2019
Rounds: 2

About

Embleema is a real-world evidence (RWE) platform that enables life sciences companies to run registries, Phase IV trials, and non-interventional studies using multimodal patient data including ePRO, wearables, EHR, and site data. The platform captures audit-ready data from day one, connecting 60,000+ care centers and reducing study costs by 40% versus traditional CROs. Patients can track symptoms and consent to matched research studies.

Summary

Embleema is a Crypto & Web3 company based in New York, United States, founded in 2019. It has raised $4.1M in total across 2 rounds, most recently a $3.7M Series A round in Feb 2019. Investors include Pharmagest, MassChallenge and Techstars.